Back to top
more

Inogen (INGN)

(Real Time Quote from BATS)

$8.95 USD

8.95
33,314

+0.26 (2.99%)

Updated Nov 4, 2024 11:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Medtronic Initiates Product Recall, A Drag on Neurosurgery

by Zacks Equity Research

Medtronic plc. (MDT) has initiated a voluntary product recall of all unused units of its StrataMR adjustable valves and shunts based on an increase in the product complaint rate.

    AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering

    by Zacks Equity Research

    AngioDynamics, Inc. (ANGO) announced that it has priced its underwritten public offering of 2.35 million shares of common stock.

      VWR Corp Continues its Acquisition Spree with MESM Buyout

      by Zacks Equity Research

      VWR Corporation (VWR) recently acquired a global provider of laboratory and medical equipment and ancillary supplies to clinical trials, MESM Ltd.

        Here's Why You Should Dump Tenet Healthcare (THC) Stock Now

        by Zacks Equity Research

        Texas-based health care services company Tenet Healthcare Corp. (THC) seems to have fallen out of favor with investors.

          ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern

          by Zacks Equity Research

          On Apr 7, we issued an updated research report on Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer.

            Hill-Rom's Innovations Make Surgeries More Safe, Accurate

            by Zacks Equity Research

            Hill-Rom Holdings, Inc. (HRC) recently demonstrated the impact of surgical patient positioning on skin and nerve pressure-related injuries.

              Becton (BDX) Gets FDA 510(k) for New Flow Cytometer System

              by Zacks Equity Research

              Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

                Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital

                by Zacks Equity Research

                Fresenius Medical Care AG & Co. KGAA announced the acquisition of 70% equity interest in Kunming Wuhua Health Hospital in China.

                  PetMed Faces Concerns over New Order Sales, Competition

                  by Zacks Equity Research

                  On Apr 6, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

                    athenahealth Now a Strong Buy: Should You Add the Stock?

                    by Zacks Equity Research

                    On Apr 5, athenahealth (ATHN) was raised to a Zacks Rank #1 (Strong Buy).

                      Medtronic (MDT) Less-Invasive HVAD Pump Results Positive

                      by Zacks Equity Research

                      Medtronic plc (MDT), a leading name in medical device space, recently presented preliminary results from its HVAD LATERAL study.

                        Medidata & TESARO Win CARE 'Clinical Partnership' Award

                        by Zacks Equity Research

                        Medidata Solutions Inc. (MDSO) recently announced the receipt of the 'Clinical Partnership of the Year' award at the second annual Clinical and Research Excellence (CARE) Awards, courtesy of its 'unique technology collaboration' with TESARO.

                          Omnicell's Aesynt Buyout Looks Promising amid Several Woes

                          by Zacks Equity Research

                          On Apr 6, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

                            Mazor Expects Higher Q1 Revenue, Receives Mazor X Orders

                            by Zacks Equity Research

                            Mazor Robotics Ltd. (MZOR), recently announced that it expects to report record first-quarter 2017 revenue of approximately $11.5 million compared with only $6.4 million in the year-ago quarter.

                              Medtronic HVAD System Results Positive for Long-Term Therapy

                              by Zacks Equity Research

                              Medical device major Medtronic plc (MDT) recently released results of its ENDURANCE Supplemental trial in regard to HVAD System.

                                IDEXX Laboratories' CAG Revenues Solid, Competition Rife

                                by Zacks Equity Research

                                On Apr 5, we issued an updated research report on Delaware NJ-based IDEXX Laboratories, Inc. (IDXX).

                                  Walgreens Boots (WBA) Meets Q2 Earnings, Retains EPS View

                                  by Zacks Equity Research

                                  Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.36 in second-quarter fiscal 2017, up 6.1% year over year.

                                    Should You Retain Acadia Healthcare Stock in Your Portfolio?

                                    by Zacks Equity Research

                                    The Acadia Healthcare Company, Inc. (ACHC) stock gained momentum in the first quarter of 2017

                                      Teleflex (TFX) Acquires Medical Device Provider Pyng Medical

                                      by Zacks Equity Research

                                      Teleflex Inc. (TFX), a global provider of medical technologies, announced that it has acquired Pyng Medical Corporation.

                                        Becton, Dickinson Takes Over Caesarea Medical Electronics

                                        by Zacks Equity Research

                                        Becton, Dickinson and Company (BDX), popularly known as BD, recently announced that it has acquired Caesarea Medical Electronics.

                                          WellCare and Catholic Health Team Up to Improve Health Care

                                          by Zacks Equity Research

                                          WellCare of New York, Inc., a wholly owned subsidiary of WellCare Health Plans, Inc. (WCG), recently inked a deal with Catholic Health and Catholic Medical Partners to enhance its health care services.

                                            Walgreens, Prime Form Central Specialty & Mail Service Company

                                            by Zacks Equity Research

                                            Walgreens Boots Alliance (WBA), in a partnership with pharmacy benefit manager (PBM) Prime Therapeutics LLC, recently formed a combined central specialty pharmacy and mail services company AllianceRx .

                                              Varian (VAR) Eclipse Software Tops in International Studies

                                              by Zacks Equity Research

                                              Varian Medical Systems, Inc. (VAR) recently announced that its Eclipse treatment planning software has topped in two competitive international plan studies.

                                                NuVasive Receives FDA 510(k) Clearance in Cervical Spine

                                                by Zacks Equity Research

                                                NuVasive Inc. (NUVA) received the U.S. FDA's 510(K) clearance for one of its spine products.

                                                  Amedisys to Buy East Tennessee to Expand in Personal Care

                                                  by Zacks Equity Research

                                                  Amedisys Inc. (AMED) recently signed a definitive agreement to buy substantially all of the assets of a Knoxville, TN-based personal care provider, East Tennessee Personal Care Service.